D. Boral Capital Maintains Buy on VolitionRX, Lowers Price Target to $3

Benzinga · 2d ago
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $5 to $3.